1. Home
  2. CCK vs FMS Comparison

CCK vs FMS Comparison

Compare CCK & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$107.91

Market Cap

12.2B

Sector

Industrials

ML Signal

HOLD

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$22.69

Market Cap

13.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCK
FMS
Founded
1906
1996
Country
United States
Germany
Employees
N/A
N/A
Industry
Containers/Packaging
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2B
13.6B
IPO Year
2003
2005

Fundamental Metrics

Financial Performance
Metric
CCK
FMS
Price
$107.91
$22.69
Analyst Decision
Buy
Sell
Analyst Count
16
2
Target Price
★ $121.19
$30.00
AVG Volume (30 Days)
★ 822.5K
635.7K
Earning Date
04-27-2026
05-05-2026
Dividend Yield
1.41%
★ 2.57%
EPS Growth
★ 79.72
N/A
EPS
★ 3.78
N/A
Revenue
★ $11,665,000,000.00
N/A
Revenue This Year
$5.17
N/A
Revenue Next Year
$2.38
$3.83
P/E Ratio
$27.96
★ $15.62
Revenue Growth
N/A
N/A
52 Week Low
$89.21
$20.02
52 Week High
$122.91
$27.64

Technical Indicators

Market Signals
Indicator
CCK
FMS
Relative Strength Index (RSI) 34.86 48.19
Support Level $97.66 $22.37
Resistance Level $109.00 $23.99
Average True Range (ATR) 2.26 0.28
MACD -0.54 0.05
Stochastic Oscillator 25.94 65.32

Price Performance

Historical Comparison
CCK
FMS

About CCK Crown Holdings Inc.

Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: